As of 2026-04-01, the Intrinsic Value of Design Therapeutics Inc (DSGN) is -5.66 USD. This DSGN valuation is based on the model Peter Lynch Fair Value. With the current market price of 10.64 USD, the upside of Design Therapeutics Inc is -153.18%.
Based on its market price of 10.64 USD and our intrinsic valuation, Design Therapeutics Inc (DSGN) is overvalued by 153.18%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -5.66 - -5.66 | -5.66 | -153.18% |
| P/E | (23.20) - (24.42) | (23.54) | -321.2% |
| DDM - Stable | (12.01) - (52.15) | (32.08) | -401.5% |
| DDM - Multi | (1.70) - (5.84) | (2.65) | -124.9% |
| Market Cap (mil) | 656.17 |
| Beta | 0.62 |
| Outstanding shares (mil) | 61.67 |
| Enterprise Value (mil) | 639.31 |
| Market risk premium | 4.60% |
| Cost of Equity | 8.28% |
| Cost of Debt | 5.00% |
| WACC | 6.08% |